Personalis Net Worth 2018-2024 | PSNL
Interactive chart of historical net worth (market cap) for Personalis (PSNL) over the last 10 years. How much a company is worth is typically represented by its market capitalization, or the current stock price multiplied by the number of shares outstanding. Personalis net worth as of November 01, 2024 is $0.27B.
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical - Generic Drugs | $0.270B | $0.073B |
| Personalis Inc. is a cancer genomics company. It is engaged in the development of therapies by providing molecular data about each patient's cancer and immune response. Personalis Inc. is based in Menlo Park, California. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Teva Pharmaceutical Industries (TEVA) | Israel | $20.902B | 7.10 |
| Dr Reddy's Laboratories (RDY) | India | $12.399B | 18.57 |
| BridgeBio Pharma (BBIO) | United States | $4.791B | 0.00 |
| Bausch Health Cos (BHC) | Canada | $3.597B | 2.61 |
| Amphastar Pharmaceuticals (AMPH) | United States | $2.469B | 13.82 |
| Supernus Pharmaceuticals (SUPN) | United States | $1.872B | 377.44 |
| Taysha Gene Therapies (TSHA) | United States | $0.314B | 51.00 |
| Assembly Biosciences (ASMB) | United States | $0.107B | 0.00 |
| Acasti Pharma (GRCE) | Canada | $0.031B | 0.00 |
| Sol-Gel Technologies (SLGL) | Israel | $0.014B | 0.00 |
| Evoke Pharma (EVOK) | United States | $0.005B | 0.00 |
| Teligent (TLGT) | United States | $0.000B | 0.00 |